SAGE: Sage Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 453.11
Enterprise Value ($M) 372.09
Book Value ($M) 465.09
Book Value / Share 7.56
Price / Book 0.97
NCAV ($M) 449.17
NCAV / Share 7.31
Price / NCAV 1.01

Profitability (mra)
Return on Invested Capital (ROIC) -0.84
Return on Assets (ROA) -0.52
Return on Equity (ROE) -0.57

Liquidity (mrq)
Quick Ratio 7.42
Current Ratio 7.42

Balance Sheet (mrq) ($M)
Current Assets 531.30
Assets 547.22
Liabilities 82.13
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 41.24
Operating Income -410.52
Net Income -400.67
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -267.19
Cash from Investing 266.68
Cash from Financing 10.66

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
5 days ago 13G Madison Avenue Partners, LP 8.00
03-07 13G/A Fmr Llc 0.80 -87.83
03-06 13G/A Morgan Stanley 1.60 -77.72
02-14 13G/A Rtw Investments, Lp 4.90 -42.23
01-31 13G/A Vanguard Group Inc 7.90 -16.01
01-17 13G/A Bb Biotech Ag 1.90 -73.58
01-10 13D Biogen Inc. 10.20 0.00
11-08 13G/A BlackRock, Inc. 8.80 0.00
10-18 13G/A State Street Corp 4.80 -25.32
06-06 13G/A Wellington Management Group Llp 0.07 -99.34

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-02-11 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2024-10-29 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-07-31 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-04-25 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-04 402,220 3,822,141 10.52
2025-04-03 149,116 924,132 16.14
2025-04-02 105,028 731,961 14.35
2025-04-01 116,440 1,205,619 9.66
2025-03-31 201,267 1,241,882 16.21

(click for more detail)

Similar Companies
RNA – Avidity Biosciences, Inc. RNAC – Cartesian Therapeutics, Inc.
RYTM – Rhythm Pharmaceuticals, Inc. SCYX – SCYNEXIS, Inc.
SGMT – Sagimet Biosciences Inc.


Financial data and stock pages provided by
Fintel.io